The Recall Desk
Agency classClass IIOur severity:ModerateFDA (Drugs)·D-0673-2022·Announced 2022-03-30

Clobetasol Propionate Ointment USP 0.05% Nationwide Recall

Teligent Pharma is recalling all unexpired batches of Clobetasol Propionate Ointment USP 0.05% nationwide because the manufacturer is discontinuing its stability study program, raising questions about product integrity.

The agency’s classification

FDA (Drugs): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 2/5 (Moderate).

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: This is an FDA Class II recall involving a cGMP deviation (discontinuation of stability testing). No illnesses, injuries, or deaths are reported. The hazard is manufacturing-process-related rather than an acute safety threat, warranting a Moderate classification consistent with precautionary Class II recalls.

Plain-English summary

Teligent Pharma, Inc. is recalling Clobetasol Propionate Ointment USP 0.05% in four package sizes: 15 grams (NDC 52565-039-15), 30 grams (NDC 52565-039-30), 45 grams (NDC 52565-039-45), and 60 grams (NDC 52565-039-60). A total of 72,826 tubes are affected.

The recall affects all products within expiry and applies nationwide in the USA and Puerto Rico. The recall was initiated because the firm is discontinuing its stability study program, which represents a deviation from current Good Manufacturing Practice (cGMP) requirements.

Affected batches include: 15g tubes (batch 15856, exp. 8/31/2022; batch 17026, exp. 6/30/2023); 30g tubes (batch 15856, exp. 8/31/2022; batch 17026, exp. 6/30/2023; batch 17046, exp. 6/30/2023); 45g tubes (batch 15856, exp. 8/31/2022); and 60g tubes (batch 15856, exp. 8/31/2022; batch 17026, exp. 6/30/2023).

Consumers and healthcare providers should discontinue use of the affected product. Patients taking this prescription ointment should contact their healthcare provider for guidance on alternative treatments.

The recalled product

Product
Clobetasol Propionate Ointment USP, 0.05%, packaged in a) 15 grams tube, NDC 52565-039-15; b) 30 grams tube, NDC 52565-039-30; c) 45 grams tube, NDC 52565-039-45; d) 60 grams tube, NDC 52565-039-60, Rx only, Manufactured by: Teligent Pharma, Inc., Buena, NJ 08310.
Manufacturer
Teligent Pharma, Inc.
Category
Drug — Topical Corticosteroid
Hazard
Affected units
72,826

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (8)

  • Batch: a) 15856
  • Exp. 8/31/2022
  • 17026
  • Exp. 6/30/2023
  • b) 15856
  • 17046
  • c) 15856
  • d) 15856

Distribution

Distributed nationwide across the United States.

The notice also names 1 state specifically:

Part of a larger recall action

This product is one of 37 recalled by Teligent Pharma, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 37 products in this recall →

Related recalls

Same manufacturer · Teligent Pharma, Inc.

See all →

Same hazard · cgmp deviation

See all →

Similar recalls